• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门诊成年患者中白喉、破伤风和百日咳的血清阳性率较低:终身接种疫苗的必要性。

Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination.

作者信息

Tanriover Mine Durusu, Soyler Canan, Ascioglu Sibel, Cankurtaran Mustafa, Unal Serhat

机构信息

Hacettepe University Faculty of Medicine, Department of Internal Medicine, Section of General Internal Medicine, 06100, Sıhhiye, Ankara, Turkey.

Hacettepe University Faculty of Medicine, Department of Internal Medicine, Section of General Internal Medicine, 06100, Sıhhiye, Ankara, Turkey.

出版信息

Eur J Intern Med. 2014 Jul;25(6):528-32. doi: 10.1016/j.ejim.2014.04.010. Epub 2014 May 9.

DOI:10.1016/j.ejim.2014.04.010
PMID:24814432
Abstract

BACKGROUND

Tetanus, diphtheria, pertussis and measles are vaccine preventable diseases that have been reported to cause morbidity and mortality in adult population in the recent years. We aimed to document the seropositivity rates and vaccination indication for these four vaccine preventable diseases among adult and elderly patients who were seen as outpatients in a university hospital.

METHODS

Blood samples for tetanus, diphtheria, pertussis and measles antibodies were obtained. Results were evaluated with regards to protection levels and booster vaccine indications according to the cut-off values.

RESULTS

A total of 1367 patients consented for the study and 1303 blood samples were available for analysis at the end of the study. The antibody levels against measles conferred protection in 98% of patients. However, 65% of the patients had no protection for diphtheria, 69% had no protection for tetanus and 90% of the patients had no protection for pertussis. Only 1.3% of the study population had seropositivity against three of the diseases-Tdap booster was indicated in 98.7%. Multivariable logistic regression showed that tetanus protection decreased with increasing age. Having a chronic disease was associated with a lower rate of protective antibodies for pertussis.

CONCLUSIONS

We demonstrated very low rates of protection against three of the vaccine preventable diseases of childhood-diphtheria, pertussis and tetanus. Booster vaccinations are required in adult life in accordance with national and international adult vaccination guidelines. The concept of "lifelong vaccination" should be implemented and every encounter with the patient should be regarded as a chance for catch-up.

摘要

背景

破伤风、白喉、百日咳和麻疹是疫苗可预防疾病,近年来有报道称这些疾病在成人中会导致发病和死亡。我们旨在记录在一所大学医院门诊就诊的成年和老年患者中这四种疫苗可预防疾病的血清阳性率和疫苗接种指征。

方法

采集破伤风、白喉、百日咳和麻疹抗体的血样。根据临界值,就保护水平和加强疫苗指征对结果进行评估。

结果

共有1367名患者同意参与本研究,研究结束时1303份血样可供分析。98%的患者体内抗麻疹抗体水平具有保护作用。然而,65%的患者对白喉没有保护作用,69%的患者对破伤风没有保护作用,90%的患者对百日咳没有保护作用。仅1.3%的研究人群对三种疾病血清呈阳性——98.7%的患者需要接种破伤风类毒素、白喉、无细胞百日咳联合疫苗(Tdap)加强针。多变量逻辑回归显示,破伤风保护作用随年龄增长而降低。患有慢性病与百日咳保护性抗体水平较低相关。

结论

我们发现针对儿童期三种疫苗可预防疾病——白喉、百日咳和破伤风的保护率非常低。应根据国家和国际成人疫苗接种指南在成年期进行加强接种。应实施“终身接种”的理念,每次与患者接触都应视为补种的机会。

相似文献

1
Low seroprevalence of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination.门诊成年患者中白喉、破伤风和百日咳的血清阳性率较低:终身接种疫苗的必要性。
Eur J Intern Med. 2014 Jul;25(6):528-32. doi: 10.1016/j.ejim.2014.04.010. Epub 2014 May 9.
2
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.一项关于破伤风、白喉和无细胞百日咳(Tdap)疫苗与破伤风和白喉(Td)疫苗作为健康成年人加强针时的安全性和免疫原性的随机、双盲、非劣效性临床试验比较。
Vaccine. 2012 Aug 10;30(37):5464-71. doi: 10.1016/j.vaccine.2012.06.073. Epub 2012 Jul 6.
3
Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.成人接种含低剂量抗原的白喉-破伤风-无细胞百日咳疫苗(Tdap)初免加强后 9 年,抗体持久性、安全性和免疫原性。
Vaccine. 2018 Oct 8;36(42):6325-6333. doi: 10.1016/j.vaccine.2018.08.051. Epub 2018 Sep 7.
4
Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US.含低剂量抗原的破伤风、白喉和无细胞百日咳联合疫苗(Boostrix):在美国,10-64 岁人群中作为单剂加强免疫接种的使用评价。
BioDrugs. 2009;23(4):253-67. doi: 10.2165/11202770-000000000-00000.
5
Seroprevalence of antibodies against diphtheria, tetanus, and pertussis among healthy Thai adolescents.泰国健康青少年对白喉、破伤风和无细胞百日咳的抗体血清流行率。
Int J Infect Dis. 2020 Jul;96:422-430. doi: 10.1016/j.ijid.2020.04.088. Epub 2020 May 6.
6
Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.美国成年人的破伤风-白喉-无细胞百日咳疫苗接种
Expert Rev Vaccines. 2008 Jul;7(5):621-34. doi: 10.1586/14760584.7.5.621.
7
Immunogenicity of reduced antigen content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.抗原含量降低的破伤风-白喉-无细胞百日咳疫苗作为含无细胞百日咳疫苗的第六剂在青少年中的免疫原性。
Vaccine. 2007 Jul 20;25(29):5248-52. doi: 10.1016/j.vaccine.2007.05.012. Epub 2007 Jun 4.
8
Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.泰国孕妇单次接种低剂量无细胞百白破联合疫苗(Tdap)后的博德特氏菌属百日咳抗体血清阳性率和抗百日咳抗体应答。
Vaccine. 2020 Mar 10;38(12):2725-2733. doi: 10.1016/j.vaccine.2020.01.074. Epub 2020 Feb 16.
9
Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.在过去20年未接种含白喉和破伤风疫苗的40岁及以上成年人中,一剂白喉、破伤风、无细胞百日咳和脊髓灰质炎疫苗(Repevax®)后再接种两剂白喉、破伤风和脊髓灰质炎疫苗(Revaxis®)的免疫原性和安全性。
Vaccine. 2014 Jun 30;32(31):3942-9. doi: 10.1016/j.vaccine.2014.05.034. Epub 2014 May 19.
10
Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A cross-sectional study in children following vaccination procedure in Guangzhou, China.针对百日咳、白喉、破伤风、麻疹、腮腺炎和风疹抗体的血清阳性率:中国广州接种疫苗程序后儿童的横断面研究。
Vaccine. 2020 May 13;38(23):3960-3967. doi: 10.1016/j.vaccine.2020.03.056. Epub 2020 Apr 19.

引用本文的文献

1
Mortality and risk factors in hospitalised adult patients with tetanus: a systematic review and meta-analysis.住院成年破伤风患者的死亡率及危险因素:一项系统评价与荟萃分析。
BMJ Open. 2025 Jul 28;15(7):e101782. doi: 10.1136/bmjopen-2025-101782.
2
The Present and Future Aspects of Life-Long Pertussis Prevention: Narrative Review with Regional Perspectives for Türkiye.终身预防百日咳的现状与未来展望:基于土耳其地区视角的叙述性综述
Infect Dis Ther. 2023 Nov;12(11):2495-2512. doi: 10.1007/s40121-023-00876-0. Epub 2023 Oct 10.
3
Review of Vaccination Recommendations in Guidelines for Non-Communicable Diseases with Highest Global Disease Burden among Adults 75 Years Old and Above.
75岁及以上成年人中全球疾病负担最高的非传染性疾病指南中的疫苗接种建议综述
Vaccines (Basel). 2023 Jun 8;11(6):1076. doi: 10.3390/vaccines11061076.
4
Pertussis prevalence among adult patients with acute cough.成年急性咳嗽患者中的百日咳患病率。
Turk J Med Sci. 2022 Jun;52(3):580-586. doi: 10.55730/1300-0144.5349. Epub 2022 Jun 16.
5
Factors associated with in-hospital mortality of adult tetanus patients-a multicenter study from Bangladesh.与成人破伤风患者住院死亡率相关的因素-来自孟加拉国的一项多中心研究。
PLoS Negl Trop Dis. 2022 Mar 1;16(3):e0010235. doi: 10.1371/journal.pntd.0010235. eCollection 2022 Mar.
6
Healthcare personnel's attitude and coverage about tetanus vaccination in Turkey: a multicenter study.土耳其医疗保健人员对破伤风疫苗接种的态度和覆盖面:一项多中心研究。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2014732. doi: 10.1080/21645515.2021.2014732. Epub 2022 Feb 16.
7
Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population.马来西亚人群中白喉类毒素 IgG 抗体的血清阳性率。
BMC Infect Dis. 2021 Jun 16;21(1):581. doi: 10.1186/s12879-021-06285-3.
8
The maternal antibody against diphtheria, tetanus and pertussis showed distinct regional difference in China.中国针对白喉、破伤风和百日咳的母体抗体呈现出明显的区域性差异。
BMC Pediatr. 2019 Dec 7;19(1):480. doi: 10.1186/s12887-019-1860-5.
9
Factors Influencing Persistence of Diphtheria Immunity and Immune Response to a Booster Dose in Healthy Slovak Adults.影响斯洛伐克健康成年人白喉免疫力持久性及加强剂量免疫反应的因素
Vaccines (Basel). 2019 Oct 7;7(4):139. doi: 10.3390/vaccines7040139.
10
The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context.意大利慢性阻塞性肺疾病患者百日咳预防需求未得到满足的情况。
Hum Vaccin Immunother. 2020;16(2):340-348. doi: 10.1080/21645515.2019.1652517. Epub 2019 Sep 6.